TipRanks
Knight Therapeutics (KHTRF)
OTHER OTC:KHTRF
US Market
KHTRF
Knight Therapeutics
RESEARCH TOOLSreports

Knight Therapeutics (KHTRF) Stock News & Sentiment

33 Followers
Analyst Reiterates Buy on Knight Therapeutics, Citing Strong Q2 Beat, Raised Guidance and DCF-Supported C$12 Target Price
Premium
Ratings
Analyst Reiterates Buy on Knight Therapeutics, Citing Strong Q2 Beat, Raised Guidance and DCF-Supported C$12 Target Price
2M ago
KHTRF Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
KHTRF Earnings this Week: How Will it Perform?
2M ago
Analyst Lifts Knight Therapeutics Price Target to $12 on Strong Outperformance and Upgraded 2026 Outlook, Reiterates Buy Rating
Premium
Ratings
Analyst Lifts Knight Therapeutics Price Target to $12 on Strong Outperformance and Upgraded 2026 Outlook, Reiterates Buy Rating
5M ago
Knight Therapeutics Doubles Down on Earnings Momentum
Premium
Company Announcements
Knight Therapeutics Doubles Down on Earnings Momentum
5M ago
Knight Therapeutics Posts Record 2025 Revenue, Sets Confident 2026 Outlook
Premium
Company Announcements
Knight Therapeutics Posts Record 2025 Revenue, Sets Confident 2026 Outlook
7M ago
KHTRF Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
KHTRF Upcoming Earnings Report: What to Expect?
7M ago
Knight Therapeutics Reports Record Revenues Amid Challenges
Premium
Company Announcements
Knight Therapeutics Reports Record Revenues Amid Challenges
11M ago
More KHTRF News >

KHTRF News on the Web

Analysts Offer Insights on Healthcare Companies: Knight Therapeutics (OtherKHTRF) and Ovid Therapeutics (OVID)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Knight Therapeutics (OtherKHTRF) and Chemomab Therapeutics (CMMB)
TipRanks News
Bullish
Knight Therapeutics price target raised to C$8.50 from C$8 at RBC Capital
TipRanks News
Bullish
RBC Capital Remains a Buy on Knight Therapeutics (KHTRF)
TipRanks News
Bullish
Knight Therapeutics Inc (KHTRF) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ...
GuruFocus News
Bullish
Knight Therapeutics Posts Record 2025 Revenue, Sets Confident 2026 Outlook
TipRanks News
Neutral
Knight Therapeutics sees FY26 revenue C$490M-C$510M
TipRanks News
Bullish
Knight Therapeutics reports Q4 EPS C$0.09 vs. C$0.11 last year
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.5 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KHTRF’s Media Buzz Sentiment?
Currently, no data Available
What is KHTRF’s weekly average amount of articles?
In an average week, 0.5 articles about KHTRF are published.
    What is KHTRF’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    REGNRegeneron
    QTTBQ32 Bio
    NVSNovartis
    RHHVFRoche Holding AG
    KRROKorro Bio
    Showing the stocks with the most bullish news sentiment over the past week